Search results
Found 6785 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Molnupiravir doesn't reduce COVID-19 hospitalisations in high-risk vaccinated people
Clinical Trials General Research
3 January 2023
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.
Professor Marian Knight recognised for services to maternal and public health
Awards and Appointments General
31 December 2022
Professor Knight's research focuses on the care and prevention of severe complications of pregnancy and early life and addressing disparities in outcomes for women and babies from different population groups.
Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award
Awards and Appointments General
20 December 2022
A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
Making smiles
General
19 December 2022
Photographer in Residence at Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, Pearl Gan's photograph is featured as one of the winners in The Lancet's Highlights 2022. Highlights is The Lancet's annual photography competition and this year's competition focussed on health-related topics.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
General Research
16 December 2022
New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Oxford Ebola vaccine manufactured and shipped in record time by SII
General Research
16 December 2022
More than 40,000 doses of Oxford’s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
‘Thinking Family’ when an adult has a serious illness
General Research
15 December 2022
Every day, thousands of parents and grandparents are diagnosed with serious health conditions such as cancer, lung or heart disease. They are then faced with the unenviable task of sharing this information with the children they love.
Director of MRC Brain Network Dynamics Unit appointed
Awards and Appointments General
15 December 2022
From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.
Nearly 1 in 10 young people experience physical pain and suicidality
General Research
14 December 2022
Nearly one in 10 young people are experiencing both persistent physical pain and suicidal feelings, according to a new paper from researchers from the University of Oxford, Cambridge, Oslo (Norway), King’s College London, and the Parc Sanitari Sant Joan de Deu (Spain).
December 2022 - Volunteer Opportunities
13 December 2022
Doctors regularly give ineffective weight loss advice to patients with obesity, study reveals
General Research
13 December 2022
A study published today in 'Family Practice', led by researchers at the University of Oxford, finds that when doctors tell patients living with obesity to lose weight, the guidance they give is generally vague, superficial, and commonly not supported by scientific evidence.
DPUK welcomes government’s £50m investment in MND research
General Research
13 December 2022
Part of this new funding will help the Dementias Platform UK team work with the MND community to translate scientific discoveries into real-world treatments.
Alexandra Preston receives ASH Outstanding Abstract Achievement Award
Awards and Appointments General Staff and student stories
12 December 2022
Alexandra Preston, a doctoral student from MRC Human Immunology Unit (MRC Weatherall Institute of Molecular Medicine), delivered a plenary talk on 11th December at the ASH Meeting and Exposition in New Orleans, Louisiana.
Demis Hassabis Visited Kavli INsD for the Kavli Award Lecture 2022
Awards and Appointments General
12 December 2022
In his talk, Demis mentioned how they were able to solve the protein folding problem with AlphaFold. For 50 years, people have been working on protein folding, a problem first articulated by Nobel Prize winner Christian Anfinsen.
Research confirms important differences in colorectal cancer patients with a history of Inflammatory Bowel Disease
General Research
12 December 2022
IBD-associated colorectal cancers were found to occur in younger patients and have worse outcomes. Researchers call for urgent improvement of early detection methods to provide more risk-based and personalised care.
Research at the Outbreak of a Pandemic – thanking our donors
Coronavirus COVID-19 General
12 December 2022
A 35-page full-colour report was sent out to hundreds of donors as a thank you for their important contributions, and to show them the difference they helped to make during the pandemic.
Revisions to CUREC approved procedures
8 December 2022
MSD Research Staff Forum update: Supporting researcher networks and career development
6 December 2022
Researcher representatives and advocates shared ideas to strengthen local networks and promote professional development.
EAVI2020: The Quest for an HIV Vaccine
General Research
2 December 2022
In this long read published to coincide with International AIDS Day, we explore how an international collaboration – of which the University of Oxford is a key partner – has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.